Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bcworldpharm Co's Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₩3,369 Mil. Therefore, Bcworldpharm Co's EV-to-EBIT ratio for today is 30.84.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bcworldpharm Co's Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₩11,575 Mil. Therefore, Bcworldpharm Co's EV-to-EBITDA ratio for today is 8.98.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bcworldpharm Co's Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₩80,328 Mil. Therefore, Bcworldpharm Co's EV-to-Revenue ratio for today is 1.29.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Bcworldpharm Co's Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-598 Mil. Therefore, Bcworldpharm Co's EV-to-FCF ratio for today is -173.68.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Bcworldpharm Co (XKRX:200780) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,369 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩11,575 Mil.
Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩80,328 Mil.
Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,741 Mil.
Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil.
Bcworldpharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-598 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bcworldpharm Co Enterprise Value Related Terms
Bcworldpharm Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for Bcworldpharm Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:200780 vs LLY, JNJ, ABBV: Enterprise Value Comparison
For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bcworldpharm Co Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Bcworldpharm Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Bcworldpharm Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ₩103,914 Mil mean?
Bcworldpharm Co (XKRX:200780) has a Enterprise Value of ₩103,914 Mil as of Sep. 13, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bcworldpharm Co and its competitors.
Is Bcworldpharm Co's Enterprise Value too high?
Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Enterprise Value compare to LLY and JNJ?
Bcworldpharm Co's Enterprise Value of ₩103,914 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bcworldpharm Co and its competitors. Bcworldpharm Co's current Enterprise Value is ₩103,914 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current Enterprise Value is ₩103,914 Mil. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Enterprise Value is ₩103,914 Mil as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?
Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued.
The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85.
GuruFocus considers Bcworldpharm Co to be Possible Value Trap.
Key valuation signals for XKRX:200780:
Enterprise Value: ₩103,914 Mil
GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score
Get the complete analysis for XKRX:200780
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:200780 has been successfully added to your 
